SCHEMBL7038602

SCHEMBL7038602

COC(=O)c1cc(-c2cccc(C(F)(F)F)c2)ccc1NC(=O)c1ccc(Cl)cc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 7/20 0.54
▸ PPARA Q07869 4/20 0.53
▸ MAPT P10636 4/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ TP53 P04637 2/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ RXFP1 Q9HBX9 4/20 0.48
▸ KDM4E B2RXH2 1/20 0.47
▸ ACLY P53396 1/20 0.45
▸ SLC2A1 P11166 1/20 0.45
▸ P2RX1 P51575 1/20 0.45
▸ P2RX4 Q99571 1/20 0.45
▸ P2RX7 Q99572 1/20 0.45
▸ TMPRSS4 Q9NRS4 1/20 0.45
▸ PPARD Q03181 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7039317 0.99 PPARG (0.53) PPARGPPARAMAPTMEN1ALDH1A1
Lithium SCHEMBL7039319 0.99 PPARG (0.53) PPARGPPARAMAPTMEN1ALDH1A1
SCHEMBL7037931 0.89 PPARG (0.61) PPARGPPARAMAPTMEN1ALDH1A1
SCHEMBL7041638 0.87 PPARG (0.60) PPARGPPARAMAPTALDH1A1TP53
Lithium Ion SCHEMBL7036019 0.87 PPARG (0.71) PPARGPPARAMAPTMEN1ALDH1A1
SCHEMBL7038586 0.86 PPARG (0.61) PPARGPPARAALDH1A1TP53SMN1; SMN2
SCHEMBL7040693 0.86 PPARG (0.60) PPARGPPARAMAPTMEN1ALDH1A1
SCHEMBL7038678 0.83 PPARG (0.76) PPARGPPARAMAPTALDH1A1LMNA
SCHEMBL7037291 0.83 PPARG (0.52) PPARGPPARAMAPTMEN1ALDH1A1
SCHEMBL7038571 0.82 PPARG (0.57) PPARGPPARAMAPTMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073862-A1 Compounds BIOVITRUM AB (SE) 2003-04-17 — — US disclosed
WO-2003004458-A1 NEW COMPOUNDS BIOVITRUM AB (SE) 2003-01-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073862-A1 Compounds PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885MAPT 4479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback